Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 96 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Vassiliki Kotoula [Clear All Filters]
Lack of association between KRAS mutations and 18F-FDG PET/CT in Caucasian metastatic colorectal cancer patients..
Anticancer Res. 34(5), 2571-9.
(2014). Mutational profiling of the RAS, PI3K, MET and b-catenin pathways in cancer of unknown primary: a retrospective study of the Hellenic Cooperative Oncology Group..
Clin Exp Metastasis. 31(7), 761-9.
(2014). Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression..
Anticancer Res. 34(9), 4949-62.
(2014). Prognostic significance of the Wnt pathway in squamous cell laryngeal cancer..
Oral Oncol. 50(4), 298-305.
(2014). Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer..
Anticancer Res. 34(11), 6495-503.
(2014).
(2014). Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel..
Pharmacogenomics J. 14(3), 248-55.
(2014). Evaluation of two highly-multiplexed custom panels for massively parallel semiconductor sequencing on paraffin DNA..
PLoS One. 10(6), e0128818.
(2015). Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial..
PLoS One. 10(5), e0124612.
(2015). Impact of tumor angiogenic profile on the outcome of patients with metastatic breast carcinoma treated with weekly docetaxel. A Hellenic Cooperative Oncology Group (HeCOG) study..
Histol Histopathol. 30(9), 1129-41.
(2015). Intact or broken-apart RNA: an alternative concept for ALK fusion screening in non-small cell lung cancer (NSCLC)..
Appl Immunohistochem Mol Morphol. 23(1), 60-70.
(2015). Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer..
J Natl Cancer Inst. 107(8),
(2015). p85 protein expression is associated with poor survival in HER2-positive patients with advanced breast cancer treated with trastuzumab..
Pathol Oncol Res. 21(2), 273-82.
(2015). Prognostic and predictive role of vascular endothelial growth factor polymorphisms in breast cancer..
Pharmacogenomics. 16(1), 79-94.
(2015).
(2015).
(2015). Disease evolution and heterogeneity in bilateral breast cancer..
Am J Cancer Res. 6(11), 2611-2630.
(2016). Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes..
Breast Cancer Res Treat. 158(2), 307-21.
(2016). Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma..
Clin Cancer Res. 22(3), 704-13.
(2016). Expression Patterns of Growth and Survival Genes with Prognostic Implications in Advanced Pancreatic Cancer..
Anticancer Res. 36(12), 6347-6356.
(2016). Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes..
Breast Cancer Res Treat. 157(1), 117-31.
(2016). Interaction Between Beta-Catenin and EGFR Expression by Immunohistochemistry Identifies Prognostic Subgroups in Early High-risk Triple-negative Breast Cancer..
Anticancer Res. 36(5), 2365-78.
(2016). TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting..
Oncotarget. 7(22), 32731-53.
(2016). Tubular Pyloric Gland Adenoma of the Left and Right Hepatic Ducts: Report of a Unique Case With Immunohistochemical and Molecular Studies..
Int J Surg Pathol. 24(4), 347-52.
(2016).
(2016).